Vyome vs Lisata Therapeutics
HIND and LSTA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How HIND and LSTA compare
Vyome and Lisata Therapeutics are about the same size, with market caps of $11.1M and $10.9M.
Vyome grew revenue faster over the last twelve months (−55.6% versus −90.7% for Lisata Therapeutics).
Vyome keeps more of each dollar of sales as profit, with a net margin of −2456% compared with −17159% at Lisata Therapeutics.
Lisata Therapeutics scores higher on the StockData Score (6 against 1 for Vyome), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | HIND | LSTA |
|---|---|---|
| Size and price | ||
| Market cap | $11.1M | $10.9M |
| Share price | $1.58 | $1.21 |
| Change, 1 year | −70.3% | −44.0% |
| Change, 5 years | −100.0% | −92.2% |
| Beta (5Y) | 1.56 | 0.74 |
| Employees | 18 | 21 |
| StockData Score | ||
| Total score | 1 | 6 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 72.4× (better) | 109× |
| P/B | – | 1.4× |
| FCF yield | – | −199% |
| Growth | ||
| Revenue growth (TTM) | −55.6% (better) | −90.7% |
| Revenue growth, 5Y average | −51.0% | – |
| Profitability | ||
| Gross margin | 50.4% | – |
| Operating margin | −2854% (better) | −22043% |
| Net margin | −2456% (better) | −17159% |
| FCF margin | – | −21662% |
| Return on equity | −149% | −137% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −229.3× | – |
| Current ratio | 3.68 | 14.09 (better) |
| Altman Z-score | −12.31 | −0.75 (better) |
| Piotroski F-score | 4 (better) | 1 |
| Dividends and buybacks | ||
| Buyback yield | −53.1% | −2.1% (better) |
| Shareholder yield | −53.1% | −2.1% (better) |
| Ownership | ||
| Held by institutions | 2.0% | 12.1% |
| Held by insiders | 6.8% | 11.6% |
| Short interest, % of float | 0.28% | 0.43% |
Go deeper
- HIND stock overview
- HIND income statement
- HIND valuation and score
- LSTA stock overview
- LSTA income statement
- LSTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.